Home›Stocks›BCDA

BCDA — structural market context

BioCardia, Inc.

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 16. Each line shows the earlier value, the later value and their dates.

Price

Close $0.92 (Oct 16) vs $0.94 (Oct 15): −1.96%.

Volume

0.43× its 20-session average (246K) on Oct 16.

Includes pre- and post-market trading.

Short interest

Short interest 619K shares (settlement Sep 30) vs 864K (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Fails-to-deliver

Latest file (settlements Sep 15–Sep 30, published Oct 16): 5 days with fails, largest 96K shares on Sep 22.

Previous file (settlements Sep 1–Sep 14, published Sep 30): no fails listed.

Insider filings (Form 4)

None recorded in this window.

BCDA short interest & days to cover

SHARES SHORT
619K
% OF FLOAT
—
DAYS TO COVER
1.3
CHANGE VS PRIOR
-28.3%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (17d ago)

BCDA fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-23 · 24d83K$1.05
2026-09-22 · 25d96K$1.08
2026-09-21 · 26d10K$1.17

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

BCDA insider buying and selling (Form 4)

Last 12 months, Form 4 codes P and S: 4 purchases · 0 sales

InsiderTypeSharesValueFiled
Altman Peter · director, officer: President and CEOBuy (P)1K$1K2026-09-30
Altman Peter · director, officer: President and CEOBuy (P)2K$2K2026-09-23
Altman Peter · director, officer: President and CEOBuy (P)800$8722026-09-04
Altman Peter · director, officer: President and CEOBuy (P)5K$5K2026-08-18

SEC Form 4 filings: purchases and sales reported on Form 4 (transaction codes P and S) only; grants and option exercises excluded. Attributed public records.

Frequently asked questions

Are insiders buying BCDA?
In the last 12 months of SEC Form 4 filings, BCDA recorded 4 insider purchases and 0 sales reported on Form 4 (transaction codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
Is this page telling me to buy or sell BCDA?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with B

BABA · Alibaba Group Holding LimitedBE · Bloom Energy CorporationBTI · British American Tobacco p.l.cBBNX · Beta Bionics, Inc. Common StocBELFB · Bel Fuse Inc.BFLY · Butterfly Network, Inc.All B →

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.